Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 37, Issue 1, 2014, Pages 90-94

  Ermakov, Simon ^a   Hoffmayer, Kurt S ^a   Gerstenfeld, Edward P ^a   Scheinman, Melvin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antiarrhythmic medication; arrhythmogenic right ventricular cardiomyopathy; right ventricular cardiomyopathy; ventricular tachycardia

Indexed keywords

AMIODARONE; FLECAINIDE; GADOLINIUM; METOPROLOL; MEXILETINE; PREDNISONE; PROPAFENONE; SOTALOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; DERMATITIS; DISEASE DURATION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ELECTROPHYSIOLOGY; ENDOCARDIAL ABLATION; ENDOCARDIUM; FEMALE; FIBROSING ALVEOLITIS; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE BIOPSY; HEART PALPITATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; HYPOKINESIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MONOTHERAPY; PATIENT REFERRAL; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS;

ANTIARRHYTHMIC MEDICATION; ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY; RIGHT VENTRICULAR CARDIOMYOPATHY; VENTRICULAR TACHYCARDIA;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FLECAINIDE; HUMANS; MALE; MEXILETINE; RETROSPECTIVE STUDIES; SOTALOL; TACHYCARDIA, VENTRICULAR; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84891826940     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12250     Document Type: Article

References (12)

1. Corrado D, Basso C, Thiene G,. Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, prognosis, and treatment. Heart 2000; 83: 588-595.
2. Lagana SM, Parwani AV, Nichols LC,. Cardiac sarcoidosis: A pathology-focused review. Arch Pathol Lab Med 2010; 134: 1039-1046.
3. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr., Prystowsky EN, Prystowsky S., Cardiac sarcoidosis. Am Heart J 2009; 157: 9-21.
4. Basso C, Corrado D, Marcus FI, Nava A, Thiene G,. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373: 1289-300.
5. Marcus FI, Fontaine G,. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pacing Clin Electrophysiol 1995; 18: 1298-1314.
6. Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007; 50: 432-440.
7. Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 2005; 111: 3209-3216.
8. Leclercq JF, Coumel P,. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. Eur Heart J 1989; 10 (Suppl D): 61-67.
9. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G,. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
10. Wyse DG, Morganroth J, Ledingham R, Denes P, Hallstrom A, Mitchell LB, Epstein AE, et al. New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators. J Am Coll Cardiol 1994; 23: 1130-1140.
11. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412.
12. Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J,. Twenty-five years in the making: Flecainide is safe and effective for the management of atrial fibrillation. Europace 2011; 13: 161-173.